Pharmafile Logo
Pharmafocus logo
Advanced Search

Alchemab Therapeutics and Medicines Discovery Catapult awarded £1.7 million grant from Innovate UK to accelerate development of disease-modifying therapy for Huntington’s Disease

December 19, 2022
Business Services

Cambridge, UK. December 16 2022 – Alchemab Therapeutics, a biotechnology company unlocking new therapies from within the immune system, today …

News
Press release

CDC provides $12.5m grant to study real-world effectiveness of vaccines

December 16, 2022
Research and Development

The Center for Disease Control and Prevention (CDC) has given researchers at Washington University School of Medicine in St Louis, …

News

New blood test appears to detect hidden cancer

December 16, 2022
Research and Development

Biotech company Guardant Health has announced that its blood test-based cancer screening technique appears to be effective: the liquid biopsy …

News

Anumana and Pfizer team up on AI-enabled ECG algorithm for detection of cardiovascular disease

December 16, 2022
Medical Communications

Anumana, an AI-driven health technology firm, has signed a multi-year deal with Pfizer in order to develop an AI electrocardiogram …

News

Eli Lilly and Sosei Heptares enter into multi-target collaboration and license agreement for diabetes and metabolic diseases

December 16, 2022
Medical Communications

Japan-based Sosei Heptares announced that it has joined forces with UK global biopharma company Eli Lilly to discover, develop and …

News

Johnson & Johnson and Merck’s Ebola vaccines show lasting protection

December 15, 2022
Medical Communications

The two Ebola vaccines developed by Johnson & Johnson and Merck appeared successful according to two studies: they both produced …

News

European Commission approves Dupixent® as the first and only targeted medicine for prurigo nodularis

December 15, 2022
Medical Communications

Regeneron Pharmaceuticals and Sanofi have announced that the European Commission (EC) has expanded the marketing authorisation for Dupixent® (dupilumab) in …

News

LumiraDx receives $14m in funding for point-of-care TB test

December 15, 2022
Medical Communications

UK-based point-of-care diagnostics company LumiraDx has been given $14m in grants from the Bill & Melinda Gates Foundation to support …

News

New drug application for AstraZeneca’s Lynparza given more time by FDA

December 15, 2022
Medical Communications

AstraZeneca and its US collaborator, Merck, have announced that the FDA is allowing more time for the review of the …

News

FlyPharma Conference Middle East: New location announced

December 14, 2022
Business Services

FlyPharma Conferences are pleased to announce an exciting new addition to its event portfolio: FlyPharma Middle East. Taking place in …

News
Press release
david_brocklehurst

David Brocklehurst

December 14, 2022
Business Services

London, UK, 12 December 2022 – AstraZeneca UK announces the appointment of David Brocklehurst as Head of Oncology in the …

Appointment

Merck and Moderna’s mRNA cancer vaccine is successful in efficacy trial

December 14, 2022
Research and Development

Merck & Co and Moderna have partnered to utilise the mRNA technology used to combat COVID-19, however this time the …

News

ClearPoint recruits first patient in laser therapy study to treat Glioblastoma

December 14, 2022
Research and Development

California, US-based ClearPoint Neuro has recruited the first patient in a clinical trial which will use ClearPoint’s Prism Neuro Laser …

News

AI model predicts CVD risk from single chest radiograph

December 14, 2022
Research and Development

A recently-developed AI model has been shown to predict ten-year incidences with a similar level of success to the current …

News

GlaxoSmithKline enter into $3.3bn pact with Wave Life Sciences over oligonucleotides

December 14, 2022
Medical Communications

UK-based GSK has announced a partnership with American company Wave Life Sciences, valued at up to $3.3bn. The partnership will …

News

GSK chooses London’s West End for new headquarters

December 13, 2022
Medical Communications

GlaxoSmithKline has chosen to establish its new headquarters in London’s West End, on the corner of New Oxford Street and …

News

Autolus announces positive primary endpoint data in FELIX trial

December 13, 2022
Research and Development

Autolus Therapeutic, a clinical-stage biopharmaceutical company, has announced that the phase 2 FELIX clinical trial of obecabtagene autoleucel (obe-cel) in …

News

Seagen shares data for Adcetris combination for Hodgkin Lymphoma

December 13, 2022
Research and Development

Adcetris has long been one of Seagen’s top-selling and expanding products, and it has announced that the drug appeared successful …

News

RemeGen’s RC118 granted two orphan drug designations by FDA

December 13, 2022
Medical Communications

Chinese commercial-stage biotechnology company RemeGen has announced that RC118 for injection – its latest antibody-drug conjugate (ADC) – has been …

News

New blood cancer treatment appears successful for most trial patients

December 12, 2022
Research and Development

A new and experimental immunotherapy treatment has appeared successful in treating patients with multiple myeloma in an ongoing phase 1/2 …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026